REQUEST A DEMO
Total
USD $0.00
Search more companies

Nutramerican Pharma S.A.S. (Colombia)

Main Activities: All Other Miscellaneous Food Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Grocery and Related Product Merchant Wholesalers | Other Business Support Services
Full name: Nutramerican Pharma S.A.S. Profile Updated: November 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Nutramerican Pharma S.A.S. is based in Colombia, with the head office in Palmira. It operates in the All Other Miscellaneous Food Manufacturing industry. It was first established on June 30, 2016. The company’s latest financial report indicates a net sales revenue increase of 6.47% in 2023. Its’ total assets recorded a growth of 20.47%. In 2023, Nutramerican Pharma S.A.S.’s net profit margin decreased by 2.43%.

Headquarters
Km 6 Mz C Bg 1-46
Palmira; Valle del Cauca;

Contact Details: Purchase the Nutramerican Pharma S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Nutramerican Pharma S.A.S. report to view the information.
Incorporation Date:
June 30, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after Nutramerican Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
6.47%
Total operating revenue
5.87%
Operating profit (EBIT)
13.34%
EBITDA
13.27%
Net Profit (Loss) for the Period
-6.61%
Total assets
20.47%
Total equity
36.5%
Operating Profit Margin (ROS)
1.65%
Net Profit Margin
-2.43%
Return on Equity (ROE)
-12.34%
Quick Ratio
3.15%
Cash Ratio
0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?